Latest filing published 27 Feb 2023 for Vyant Bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Paul R. Hansen on record concern Vyant Bio, Inc., in the capacity of board member. In total, 9 filings cover trades dated from 30 March 2021 to 17 January 2023.
On the market, this insider has only ever bought: 1 purchase, €40k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants.
The latest filing, published on 27 February 2023, reports a transaction in Vyant Bio, Inc. The clock since the last published purchase (23 August 2021) now reads 1,882 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations